Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17507
Country/Region: South Africa
Year: 2016
Main Partner: Kheth'Impilo
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $989,614 Additional Pipeline Funding: $1,610,386

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $62,500
Care: TB/HIV (HVTB) $212,114
Care: Pediatric Care and Support (PDCS) $62,500
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $652,500
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 82
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 210
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 397
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 479
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 1,168
HTS_TST Service Delivery Point (Facility): Other PITC 2017 724
HTS_TST Service Delivery Point (Facility): Pediatric 2017 292
HTS_TST Service Delivery Point (Facility): PMTCT 2017 152
HTS_TST Sum of Aggregated Age/Sex <15 2017 292
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 876
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 1,168
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 20
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 29
PMTCT_ART Already on ART at beginning of current pregnancy 2017 4
PMTCT_ART New on ART 2017 4
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 15
PMTCT_STAT By: Known positives at entry 2017 2
PMTCT_STAT By: Number of new positives identified 2017 1
PMTCT_STAT Number of new ANC and L&D clients 2017 15
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 15
PMTCT_STAT Sum of Positives Status disaggregates 2017 3
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 5
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 15
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 14
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 37
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 95
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 180
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 217
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 530
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 6
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 14
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 15
TX_CURR Aggregated Age/Sex: <15 Female 2017 45
TX_CURR Aggregated Age/Sex: <15 Male 2017 117
TX_CURR Aggregated Age/Sex: 15+ Female 2017 221
TX_CURR Aggregated Age/Sex: 15+ Male 2017 266
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 649
TX_CURR Sum of Aggregated Age/Sex <15 2017 162
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 487
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 649
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 4
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 10
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 19
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 23
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 57
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 56
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 584
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 526
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 37
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 95
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 179
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 216
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 41
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 105
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 199
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 239
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 41
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 106
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 201
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 242
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 591
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 628
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 44
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 113
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 214
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 258
Cross Cutting Budget Categories and Known Amounts Total: $974,800
Human Resources for Health $900,000
Motor Vehicles: Purchased $74,800